Birdwatch Archive

Birdwatch Note

2024-03-23 02:36:11 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

①この査読前の文献内でも乳がん(図5-2),子宮がん(図5-3)の年齢調整死亡率はコロナ禍前も毎年増え続けており22年のそれがコロナ禍前の傾向から予測された値と違う訳ではありません ②卵巣がん(図6-1)、膵がん(図5-1)は20年から既に有意に過去の傾向から外れ増え始めています ③白血病(図6-2)と口腔がん(図6-3)は16年にも過去の傾向より有意に増えています ④また日本の悪性腫瘍の死亡はインフル流行でも増加する事が報告されています https://www.jstage.jst.go.jp/article/jjh1946/57/3/57_3_571/_pdf ⑤検診の減少と進行がんで発見される割合は20年から増加しその後の予後の悪化が懸念されてた事に注意が必要です↓ https://www.jcancer.jp/news/12418

Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1771351515917426983

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1771365296835854505
  • noteId - 1771365296835854505
  • participantId -
  • noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
  • createdAtMillis - 1711161371799
  • tweetId - 1771351515917426983
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 1
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 1
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • ①この査読前の文献内でも乳がん(図5-2),子宮がん(図5-3)の年齢調整死亡率はコロナ禍前も毎年増え続けており22年のそれがコロナ禍前の傾向から予測された値と違う訳ではありません ②卵巣がん(図6-1)、膵がん(図5-1)は20年から既に有意に過去の傾向から外れ増え始めています ③白血病(図6-2)と口腔がん(図6-3)は16年にも過去の傾向より有意に増えています ④また日本の悪性腫瘍の死亡はインフル流行でも増加する事が報告されています https://www.jstage.jst.go.jp/article/jjh1946/57/3/57_3_571/_pdf ⑤検診の減少と進行がんで発見される割合は20年から増加しその後の予後の悪化が懸念されてた事に注意が必要です↓ https://www.jcancer.jp/news/12418

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2024-03-23 02:36:11 UTC
(1711161371799)
2024-03-23 10:08:17 UTC
(1711188497288)
CURRENTLY_RATED_HELPFUL 2024-03-24 01:35:51 UTC
(1711244151884)
CURRENTLY_RATED_HELPFUL 2024-03-23 10:08:17 UTC
(1711188497288)
CURRENTLY_RATED_HELPFUL

Note Ratings

rated at rated by
2024-03-22 22:31:08 -0500 Rating Details
2024-03-22 22:24:00 -0500 Rating Details
2024-03-22 22:20:38 -0500 Rating Details
2024-03-22 22:13:49 -0500 Rating Details
2024-03-22 22:13:47 -0500 Rating Details
2024-03-22 21:54:43 -0500 Rating Details
2024-03-22 21:49:34 -0500 Rating Details
2024-03-23 09:11:10 -0500 Rating Details
2024-03-23 06:21:47 -0500 Rating Details
2024-03-23 03:15:04 -0500 Rating Details
2024-03-23 01:55:23 -0500 Rating Details
2024-03-23 01:17:28 -0500 Rating Details
2024-03-23 00:53:04 -0500 Rating Details
2024-03-23 00:44:20 -0500 Rating Details
2024-03-23 00:41:59 -0500 Rating Details
2024-03-23 00:14:38 -0500 Rating Details
2024-03-23 00:01:53 -0500 Rating Details
2024-03-22 23:47:28 -0500 Rating Details
2024-03-22 23:45:13 -0500 Rating Details
2024-03-22 23:15:19 -0500 Rating Details
2024-03-22 22:45:59 -0500 Rating Details
2024-03-22 22:40:11 -0500 Rating Details
2024-03-24 04:29:08 -0500 Rating Details
2024-03-23 04:28:10 -0500 Rating Details
2024-03-23 02:42:06 -0500 Rating Details
2024-03-23 02:07:54 -0500 Rating Details
2024-03-23 01:43:26 -0500 Rating Details
2024-03-23 01:15:17 -0500 Rating Details
2024-03-23 01:09:44 -0500 Rating Details
2024-03-23 00:18:31 -0500 Rating Details
2024-03-23 00:00:32 -0500 Rating Details
2024-03-22 23:27:14 -0500 Rating Details
2024-03-22 23:26:02 -0500 Rating Details
2024-03-22 23:25:57 -0500 Rating Details
2024-03-22 23:18:13 -0500 Rating Details
2024-03-22 23:17:44 -0500 Rating Details
2024-03-22 22:37:01 -0500 Rating Details
2024-03-22 22:33:11 -0500 Rating Details
2024-03-22 22:04:34 -0500 Rating Details
2024-03-22 22:04:22 -0500 Rating Details
2024-03-22 22:01:53 -0500 Rating Details
2024-03-22 22:01:13 -0500 Rating Details
2024-03-22 21:59:12 -0500 Rating Details
2024-03-22 21:57:57 -0500 Rating Details
2024-03-22 21:57:02 -0500 Rating Details
2024-03-22 21:46:33 -0500 Rating Details
2024-03-22 21:40:53 -0500 Rating Details
2024-03-24 01:09:23 -0500 Rating Details
2024-03-23 19:17:33 -0500 Rating Details
2024-03-23 10:13:24 -0500 Rating Details
2024-03-23 09:29:38 -0500 Rating Details
2024-03-23 03:45:27 -0500 Rating Details
2024-03-23 02:17:23 -0500 Rating Details
2024-03-23 00:54:13 -0500 Rating Details
2024-03-23 00:47:52 -0500 Rating Details
2024-03-23 00:36:42 -0500 Rating Details
2024-03-23 00:29:46 -0500 Rating Details
2024-03-23 00:09:38 -0500 Rating Details
2024-03-22 23:47:40 -0500 Rating Details
2024-03-22 23:39:09 -0500 Rating Details
2024-03-22 23:34:18 -0500 Rating Details
2024-03-22 23:26:26 -0500 Rating Details
2024-03-22 23:17:21 -0500 Rating Details
2024-03-22 23:06:02 -0500 Rating Details
2024-03-22 23:05:34 -0500 Rating Details
2024-03-22 22:59:11 -0500 Rating Details
2024-03-22 22:50:29 -0500 Rating Details
2024-03-22 22:35:36 -0500 Rating Details
2024-03-22 22:35:17 -0500 Rating Details
2024-03-22 22:34:14 -0500 Rating Details
2024-03-22 22:21:31 -0500 Rating Details
2024-03-22 22:21:06 -0500 Rating Details
2024-03-22 22:11:22 -0500 Rating Details
2024-03-22 21:53:34 -0500 Rating Details
2024-03-22 21:52:46 -0500 Rating Details
2024-03-22 21:50:23 -0500 Rating Details
2024-03-22 21:46:37 -0500 Rating Details
2024-03-22 21:42:33 -0500 Rating Details
2024-03-22 21:38:32 -0500 Rating Details
2024-03-22 21:38:09 -0500 Rating Details
2024-03-26 18:28:42 -0500 Rating Details
2024-03-26 17:38:37 -0500 Rating Details
2024-03-26 17:12:30 -0500 Rating Details
2024-03-26 16:08:00 -0500 Rating Details
2024-03-26 16:05:27 -0500 Rating Details